other_material
confidence high
sentiment neutral
materiality 0.40
Stockholders approve 6M extra shares for equity plan and 1.2M for ESPP
Envoy Medical, Inc.
- 6,000,000 additional shares authorized under Amended and Restated 2023 Equity Incentive Plan (effective May 12, 2026).
- 1,200,000 additional shares authorized under 2023 Employee Stock Purchase Plan.
- Stockholders re-elected directors Brent T. Lucas and Susan J. Kantor to Class III terms until 2029.
- Ratified EisnerAmper LLP as independent auditor for fiscal year ending December 31, 2026.
- Approved advisory executive compensation and issuance of warrants per Nasdaq Rule 5635(d).
item 5.02item 5.07item 9.01